Patients – Why NH-BMT?
Dr. Liza Bachier discusses the Northside BMT and Multiple Myeloma Programs
National Leader in Blood and Marrow Transplants:
In the top percentage nationally for transplant volumes
Among the Best matched unrelated donor (MUD) survival outcome data in the United States (www.bethematch.org) with actual one -year survival rate for 2023 is 81.9%*
NH-BMT is one of twenty national BMT CTN programs in the nation and the ONLY lead consortium site in Georgia.
Only transplant center in Georgia to collaborate with Dana Farber Cancer Institute’s Innovative Research Partnership: Blood Cancer Research Partnership (BCRP).
The NH–BMT Program meets the criteria of an excellent transplant center.
BMT physician team has completed post-hematology/oncology fellowship training in hematopoietic stem cell transplantation.
Highly trained BMT/leukemia/immunotherapy Team that includes a dedicated BMT health psychologist, social worker, clinical BMT PharmD’s, nutritional services, physical therapy, and chaplain services.
State-of-the-art facilities
Comprehensive quality management program
Among the BEST survival outcomes in United States
ONLY BMT program in the country, and the only BMT Program in Georgia, to achieve survival outcomes that significantly exceeded the expected survival rate for allogeneic and unrelated donor transplants for the last 15 consecutive reporting cycles (2009-2023). **
BMTGA physicians coordinate pre – post transplant care with your referring physician. Be assured treatment recommendations will be the most current and state-of-the-art.
Access to cutting edge Clinical Trials
Collaboration with Dana-Farber Cancer Institute on Innovative Research Partnership: This groundbreaking Blood Cancer Research Partnership (BCRP), dana-farber.org/BCRP, will bring clinical trial testing of innovative blood cancer therapies to community oncology settings across the country. NH-BMT is one of ten sites who have been selected to participate in this prestigious partnership.
NH-BMT is one of twenty national BMT Programs and Program Consortia to be selected as a Core Clinical Center for the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) and the ONLY lead consortium site in Georgia.
NCI- NCORP: Northside Hospital Cancer Institute and Lewis Cancer and Research Pavilion have partnered with Georgia CORE to participate in NCORP. After a successful first five years, a statewide cancer research consortium has been awarded a six-year grant expected to result in more than $11 million in funding from the National Cancer Institute (NCI) to enroll even more Georgians in important clinical trials.
Patient satisfaction survey for Northside Hospital’s inpatient BMT/Leukemia/ Immunotherapy unit was in the 95 percentile and likely to recommend to friends and family.***
* The American Society for Blood and Marrow Transplantation (ASBMT), The Foundation for Cellular Therapy (FACT) and the National Marrow Donor Program (NMDP) are three bone marrow transplant governing organizations that provide patients and family members with detailed information on how to identify an excellent transplant center: outstanding survival outcomes, experienced or trained staff, a comprehensive quality management program, and state-of-the-art facilities.
**For the fifteenth consecutive year (2009-2023), NH-BMT achieved survival outcomes that significantly exceeded the expected range, as reported in the Center for International Blood and Marrow Transplant Research's Final 2022 Transplant Center Specific Survival Report and from reported outcome data from Be The Match®. There were 175 adult and pediatric transplant centers included in the analysis. This survival information includes only patients who received their first allogeneic transplant between January 1, 2019, and December 31, 2021, using unrelated or related donors, and who had reported follow-up. Specific transplant center information can be found at bethematch.org.
***2023 Press Ganey HCAHPS Regulatory Survey